Solid Eyes Accelerated Approval as DMD Gene Therapy Faces FDA Uncertainty
Solid Biosciences reported Phase I/II data for its DMD gene therapy SGT‑003, showing higher microdystrophin expression and a greater proportion of positive fibers than Sarepta’s Elevidys. The results strengthen SGT‑003’s case for accelerated FDA approval, but the pathway is clouded by an upcoming leadership transition at the FDA’s Center for Biologics Evaluation and Research (CBER). Differences in patient populations between the trials temper direct efficacy comparisons. The timing of CBER’s new leadership could influence regulatory timelines for both companies.
Gut Health Supplement Relieves Arthritis Pain, Finds New Study
A new randomized trial (INSPIRE) led by the University of Nottingham found that daily supplementation with the prebiotic fiber inulin significantly reduced knee osteoarthritis pain and improved grip strength. Participants receiving inulin also showed higher levels of butyrate and GLP‑1,...
Beyond Wearables: Apple Wants Healthcare Products that Empower
At HIMSS26, Apple Health vice‑president Dr. Sumbul Ahmad Desai outlined the company’s next phase beyond wearables, emphasizing tighter integration with clinical workflows. Apple is expanding partnerships such as the Emory Hillandale Hospital rollout, where Macs, iPhones, iPads and Apple Watches...

Ditch the Darth Vader Mask for Sleep Apnea
Scientists have identified sulthiame, an old epilepsy drug, as a promising treatment for moderate‑to‑severe sleep apnea. In a German trial of 298 patients, higher doses cut breathing pauses by nearly 50% and boosted overnight oxygen levels. The findings, published in...
VR Could Reduce Anxiety for People Undergoing Medical Procedures
A study presented at the European Association of Urology Congress demonstrated that a virtual‑reality (VR) consent experience significantly improves patient understanding of shockwave lithotripsy and reduces pre‑procedure anxiety. The trial involved 150 adults aged 22 to 80 at University Hospital...
Scan that Makes Prostate Cancer Cells Glow Could Cut Need for Biopsies
Researchers presented PRIMARY2 trial data showing that PSMA PET/CT imaging can safely halve the number of biopsies required for men with suspected prostate cancer after a normal MRI. The molecular scan highlights aggressive cancer cells by making them glow, allowing...
Circuit Response to Neuromodulation Characterized with Simultaneous Deep Brain Stimulation and Precision Neuroimaging in Humans
Researchers used a 3‑T MRI‑compatible deep brain stimulation system to record extensive functional MRI data from 14 Parkinson’s disease patients over a year. Each participant completed 11.7 hours of fMRI across seven stimulation conditions at five longitudinal visits, alongside structural and...
AC Immune SA (ACIU) Q4 2025 Earnings Call Transcript
ACADIA Pharmaceuticals reported adjusted 2025 revenue of $1.08 billion, up 14% year‑over‑year, driven by strong performance of NUPLAZID and DAYBUE. NUPLAZID net sales reached $692 million with 15% growth, while DAYBUE posted $391 million, a 12% increase, aided by the newly approved DAYBUE...
Author Correction: SLAMF6 as a Drug-Targetable Suppressor of T Cell Immunity Against Cancer
A correction was issued for the Nature article on SLAMF6, adding a missing citation that links SLAMF6 over‑expression in acute myeloid leukemia to suppressed T‑cell activation, reversible by a blocking monoclonal antibody. The added reference strengthens the claim that SLAMF6...
Barinthus Biotherapeutics PLC (BRNS) Q4 2025 Earnings Call Transcript
Insmed reported a strong Q4 2025, highlighted by Brinsupri’s first full‑quarter US revenue of $144.6 million, surpassing internal benchmarks. Management set 2026 guidance of at least $1 billion for Brinsupri and projected total company revenue to more than double 2025 levels, driven...
[Therapeutics] Pyruvate Kinase Activators in Hereditary Haemolytic Anaemias: Current Evidence and Clinical Potential
Hereditary hemolytic anemias affect millions worldwide and have few disease‑modifying options. Oral pyruvate kinase activators, especially mitapivat, increase glycolytic ATP production, correcting a common metabolic defect in red cells. Clinical trials have shown efficacy in pyruvate kinase deficiency, sickle cell...
Interpretive Restraint After a Well Conducted Negative Trial
A multicentre, double‑blind, placebo‑controlled trial gave women with polycystic ovary syndrome (PCOS) 4,000 IU vitamin D daily for up to 90 days before IVF. The regimen raised serum 25‑hydroxyvitamin D levels but did not increase live‑birth rates after the first embryo...
Dr. Oz: CMS Getting a Technological Reboot
CMS Administrator Dr. Mehmet Oz announced a comprehensive modernization of the agency’s billing platform to keep pace with the evolving digital health ecosystem. The initiative focuses on integrating advanced technologies, including artificial intelligence, to streamline claim processing and enhance fraud...

San Francisco Receives $100 Million Proposition 1 Windfall to Expand Treatment Beds
San Francisco will receive roughly $100 million from California’s Proposition 1 bond to expand psychiatric and addiction treatment capacity. The money will finance 50 sub‑acute and six acute psychiatric beds at UCSF Hyde Hospital, 44 beds on Treasure Island, and a new...

Jaynie Seal to Host SKY NEWS Series on Australia’s Regional Health Services
Sky News Australia is launching a new special‑report series, *State of Health*, hosted by regional correspondent Jaynie Seal. The program travels across regional Australia to examine infrastructure, workforce and access challenges confronting hospitals and clinics serving nearly 10 million people. The...
600 Workers Reach Labor Deal with Kaiser
The International Union of Operating Engineers reached a tentative contract with Kaiser Permanente covering about 600 maintenance workers across Southern California, the Mid‑Atlantic and Colorado. The agreement, involving IUOE Locals 501, 99 and 1, provides a 21.5% wage increase over...
Vanderbilt Health President, CEO to Retire
Jeff Balser, MD, PhD, will retire on Dec. 31 after 17 years as president and CEO of Vanderbilt Health and dean of Vanderbilt University’s School of Medicine. During his tenure the system grew from a four‑hospital, $2.3 billion revenue network to...

Lawmakers Introduce Bill To Reject Companionship Exemption
Congress introduced the Fair Wages for Home Care Workers Act, aiming to repeal the longstanding companionship exemption that excludes many home care workers from minimum wage and overtime protections under the Fair Labor Standards Act. The bill, sponsored by Rep....
Hospital Margins Take a Dive
U.S. hospitals entered 2026 with operating margins at a 12‑month low, slipping to –0.6% for health systems and a 3.1‑point decline for individual hospitals. Patient demand and revenue growth slowed, especially in inpatient and emergency settings, while expense growth outpaced...
3 Healthcare Roles Bucking Hiring Trends for Younger Workers
A Stanford study using ADP payroll data finds that workers aged 22‑25 in occupations most exposed to generative AI saw a 16% relative employment decline, while older workers in the same roles remained stable. By contrast, younger workers in healthcare...
Tonix Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Operational Highlights
Tonix Pharmaceuticals announced FDA approval and U.S. launch of TONMYA, the first new fibromyalgia drug in over 15 years, in August 2025 with commercial availability beginning November 17, 2025. The company reported fourth‑quarter product revenue of $5.4 million and full‑year revenue...
Data Breach at NYC Health + Hospitals Partner Exposes Info of 5,086 Patients
A data breach at NADAP, a care‑management partner of NYC Health + Hospitals, exposed protected health information for 5,086 patients. The unauthorized access occurred around Nov. 26, 2025 and was discovered on Jan. 10, 2026, with the health system notified...
MSU Health Care’s CMO on the Biggest Barrier to Sustained Quality Improvement
MSU Health Care’s new chief medical officer, Dr. Mark Smith, says clinician burnout and disengagement are the biggest barriers to sustained quality and safety improvements. He emphasizes that addressing workforce wellness, building a culture of trust, and reducing administrative burdens...

FDA Requests Removal of Suicidal Behavior and Ideation Warning From Glucagon-Like Peptide-1 Receptor Agonist (GLP-1 RA) Medications
The FDA has asked manufacturers to strip the suicidal ideation and behavior warning from the labeling of three GLP‑1 receptor agonists—Saxenda, Wegovy and Zepbound—used for weight loss. A comprehensive safety review, including a meta‑analysis of 91 placebo‑controlled trials involving 107,910...

FDA to Recommend Additional, Earlier MRI Monitoring for Patients with Alzheimer’s Disease Taking Leqembi (Lecanemab)
The FDA is adding an earlier MRI requirement before the third Leqembi infusion to catch amyloid‑related imaging abnormalities with edema (ARIA‑E) sooner. An analysis of pharmacovigilance data revealed 101 serious ARIA‑E cases, including six deaths, many occurring before the fifth...
Apixaban Bests Rivaroxaban in New DOAC Comparison
A head‑to‑head trial (COBRRA) of 2,700 acute VTE patients found apixaban significantly lowers bleeding risk compared with rivaroxaban, while maintaining similar efficacy in preventing recurrent clots. Patients received standard dosing regimens for three months, with apixaban showing a 3.3% composite...
After Firings, Funding Cuts and a Shooting, Can a Demoralized CDC Workforce Recover?
After a wave of firings that cut roughly 3,000 positions—about a quarter of its staff—and ongoing funding reductions, the CDC remains leaderless, with Dr. Jay Bhattacharya named interim director while also overseeing the NIH. The agency also grapples with the...

CMS Guidance Reinforces Roles of Organ Procurement Organizations and Hospitals in Organ Procurement, Transplantation
On March 11, the Centers for Medicare & Medicaid Services issued new guidance clarifying the distinct roles of organ procurement organizations (OPOs) and hospitals in the organ donation process. The directive emphasizes that end‑of‑life decisions remain between patients’ families and attending...

MACPAC Recommends Increase in Wage Transparency for Home- and Community-Based Service Workers
The Medicaid and CHIP Payment and Access Commission (MACPAC) released its March 2026 report to Congress, recommending that states disclose hourly wages for home‑ and community‑based service (HCBS) workers. The proposal aims to give states clearer data for setting effective HCBS...

Medical Technology Company Stryker Disrupted Globally by Cyberattack
Stryker, a leading medical‑technology supplier, announced a cyberattack on March 11 that compromised its Microsoft environment, though no ransomware or malware was detected. The breach disrupted the company’s global operations and prompted immediate containment efforts. Stryker is coordinating with hospital networks...

Nurse Practitioners Are Rushing in to Fill the Gaps in US Health Care
Nurse practitioners (NPs) are rapidly expanding their role in U.S. health care as physician shortages persist. The NP workforce has surged from roughly 44,000 in 1999 to about 400,000 today, and more than half of the states now grant them...
New York Department of Health Issues Updated Guidance on Wage Parity Compliance Forms and Certification Submission Dates
On March 9, 2026 the New York Department of Health released updated guidance clarifying wage‑parity compliance deadlines for home‑care providers through 2025 and beyond. The guidance fixes previous uncertainty by setting firm LS300 reporting dates for 2025 (May 31, 2026) and establishing annual LS301 audit...

Medline Expands Distribution with New Texas Center
Medline announced a new 1.2‑million‑square‑foot distribution center in Midlothian, Texas, slated to become operational in the second quarter of 2027. The facility adds to the company’s network of 45 centers and marks its second hub in the Dallas‑Fort Worth market. Equipped...
Workshop Uses Astronaut Medical Emergencies to Rethink Value-Based Care
At HIMSS 2026, a workshop asked participants to redesign value‑based care using astronaut medical emergencies as a test case. Three teams examined vision loss, mental‑health crisis, and a blood‑clot scenario, scoring outcomes on mission success, compromise, strain, or failure. The...

Patients 50 Years and Older Satisfied with ACL Reconstruction
A recent AAOS presentation revealed that patients aged 50 and older experience high satisfaction after anterior cruciate ligament (ACL) reconstruction, with 91.5% meeting expectations. The NYU Langone Health retrospective study of 155 cases reported a 7.1% graft‑failure rate and a...

Advantages with Unilateral Biportal Endoscopic Lumbar Discectomy
Unilateral biportal endoscopic (UBE) lumbar discectomy combines endoscopic visualization with separate instrument access, offering wider maneuverability and enhanced ergonomics compared with traditional microdiscectomy. The technique reduces tissue trauma, infection risk, and postoperative pain, often enabling same‑day discharge for eligible patients....

Prior Authorization May Reduce Access to Important Heart Failure Drugs
A new JACC: Advances study finds prior‑authorization requirements hinder access to guideline‑recommended heart‑failure drugs, affecting 12.2% of ARNI and 14.3% of SGLT2i prescriptions. The barriers are disproportionately faced by younger, Black and Hispanic patients with non‑Medicare insurance. Authorization delays extend...
Genetic Tests Come Under Scrutiny in Trump Administration’s Fraud Crackdown
The Centers for Medicare & Medicaid Services (CMS) has issued a request for information (RFI) seeking public input on new regulatory tools to combat fraud in laboratory testing, especially genetic and molecular diagnostics. Genetic tests now represent 43% of Medicare...

Electronic Registration and Listing Compliance Program
The FDA’s Electronic Registration and Listing Compliance Program (eDRLS) safeguards the accuracy of drug registration and listing data that underpin inspections, electronic prescribing, and reimbursement systems. While automated validation rules catch many errors, the program also employs manual surveillance to...

Teens with ADHD Face Higher Risks of Anxiety and Depression
A University of Edinburgh longitudinal study of over 5,000 UK adolescents found that teens with ADHD face markedly higher rates of anxiety (≈25%) and depression (≈40%). The analysis identified low self‑esteem and parental mental‑health problems as the strongest mediators linking...

This FREE Depression ‘Treatment’ Rivals Therapy & Medication (M)
Dr. Jeremy Dean reviews a free, web‑based depression treatment that incorporates evidence‑based CBT, behavioral activation, and mindfulness. Clinical trials cited in the article show remission rates on par with antidepressants and traditional therapy, while delivering no pharmacological side effects. The...

Search for Pharmaceutical Quality Documents
The FDA has released an online searchable table of 249 pharmaceutical quality‑related guidances, MAPPs, and compliance programs. Recent entries include the Active Pharmaceutical Ingredient (API) Process Inspection compliance program (Sept 2025) and guidance on outsourcing facility inspections (Jan 2025). Topics span drug...

STAT+: Cancer Cells Can ‘Barf’ Proteins Onto Their Cell Surface. That May Create New Targets for Immunotherapies
Researchers at UCSF discovered the Src kinase, traditionally an intracellular signaling protein, displayed on the outer membrane of malignant cells. The finding, published in Science, showed surface Src was absent from healthy donor tissue, suggesting a tumor‑specific marker. This unexpected...
Beyond the Safety Check: Why First-in-Human Trials Demand a New Approach in 2026
Phase I trials have evolved from simple safety checks into data‑rich, adaptive studies that integrate biomarker strategies, exposure‑response analyses, and formulation optimization. Regulators now expect sponsors to justify Phase II dosing decisions, making early pharmacodynamic and target‑engagement data essential. Emerging biotechs face...

FDA’s Labeling Resources for Human Prescription Drugs
The FDA provides a comprehensive suite of labeling resources aimed at industry staff who develop human prescription‑drug labeling, including DailyMed, Drugs@FDA, FDALabel, and Medication Guides. These tools grant access to over 140,000 labeling documents and detailed regulatory histories. The agency...
Myopia Control Suitable for Adults, Pre-Myopes
At Vision Expo, optometrist Shalu Pal highlighted that myopia can continue to progress into adulthood, with 20‑40% of people in their 20s still experiencing significant eye growth. Recent data from a 2024 IOVS study showed an average progression of at...
AI Adoption, Innovation Lagging in Pediatrics
In a Healio Community webinar, pediatric leaders James S. Barry, MD, MBA, Clara Lin, MD, and Ryan McAdams, MD highlighted that AI adoption in pediatrics lags behind adult medicine due to safety, privacy, and cost concerns. Most AI tools are...

Study Demonstrates Reliability of Real-Time Imaging Guidance in Robotic Bronchoscopy
Noah Medical’s MATCH 2 study, published in Respiratory Medicine, evaluated robotic‑assisted bronchoscopy (RAB) with embedded digital tomosynthesis (DT) and augmented fluoroscopy (AF) in 31 patients with peripheral lung nodules. The trial reported a 96.7% overall diagnostic yield and identical 96.7%...

Coming Soon: Capstan Medical’s Next-Gen Structural Heart Robotics System
Capstan Medical announced that its second‑generation robotic catheter delivery system will debut in 2026, following successful first‑in‑human mitral valve implants in Chile, New Zealand and Brazil. The company has expanded its valve sizing portfolio to include 37 mm and 42 mm implants and...

Medical Equipment Techs Beg for Right-to-Repair Lifeline
A new Public Interest Research Group survey reveals that 83% of biomedical equipment technicians experience frequent delays in receiving parts, service keys, and manuals, while 70% say diagnostic‑tool restrictions often postpone patient care. OEMs commonly withhold passwords and overcharge for...